Pharmaceutical Executive March 5, 2021
Michael Wong

Dr. Amy P. Abernethy talks about her career moves from academia to industry to the US Food & Drug Administration.

Michael Wong speaks to Dr. Amy P. Abernethy about making the transition from oncologist to the Agency’s Principal Deputy Commissioner/Acting CIO of FDA.

Michael Wong: While some of my friends have moved from academia to industry, like you did as a Professor at Duke University to a C-Suite role at Flatiron Health, why did you join FDA and what were the key steps to make this transition?

Amy Abernethy: While my career has evolved across settings, my core focus has not changed: how do we improve the care of the patient sitting in front of me, especially by learning from...

Today's Sponsors

Teladoc Health
Premier
TripleTree

Today's Sponsors

SalesSparx
Canton & Company

Today's Sponsor

HLTH

 
Topics: FDA, Govt Agencies, Interview / Q&A, Physician, Provider, Trends
CIO must-dos: Reduce bureaucracy, boost patient experience and improve data governance
Mastering the Challenges Facing CIOs in Smaller Hospitals: One CIO’s Perspective
Which digital health tools helped hospitals weather the pandemic? 4 CIOs discuss
CIOs at children's hospitals share lessons from a year of turmoil
The CIO's and Chief Data Officer's Roles in Tackling Digital Health Literacy